IRVINE, CA, Apr 24, 2014 (Marketwired via COMTEX) -- Edwards Lifesciences Corporation EW +0.91% , the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended March 31, 2014 of $60.3 million, or $0.56 per diluted share, and non-GAAP net income of $82.1 million, or $0.76 per diluted share. Net income for the same period a year earlier was $143.9 million, or $1.24 per diluted share, and non-GAAP net income was $86.7 million, or $0.74 per diluted share. In last year’s quarter, the company recorded a special pre-tax gain of $83.6 million, which was an initial payment from Medtronic related to ongoing U.S. Andersen patent litigation.
Help employers find you! Check out all the jobs and post your resume.
